Used in pharmaceutical synthesis as a key intermediate for kinase inhibitors, particularly in the development of anticancer agents. Its structure enables selective binding to enzyme targets involved in cell signaling pathways. Commonly employed in the preparation of small-molecule drugs targeting tyrosine kinases. Also utilized in research for central nervous system therapies due to its ability to cross the blood-brain barrier. Frequently modified in medicinal chemistry to enhance potency and bioavailability.